GEN1042
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GEN1042, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors [Phase 1, Phase 2]